Erythropoietic response after intravenous iron in patients with heart failure and reduced ejection fraction with and without background treatment with sodium-glucose cotransporter 2 inhibitors (2023)
Article in International Scientific Journal
Marques, P; Matias, P; Packer, M; Vieira, JT; Vasques Nóvoa, F; Sharma, A; Mavrakanas, TA; Friões F; Ferreira, JP

Global longitudinal strain: Ready for prime time' in heart failure characterization (2023)
Article in International Scientific Journal
Donal, E; Neveu, A; Fontes-Carvalho R

Influence of ejection fraction on biomarker expression and response to spironolactone in people at risk of heart failure: findings from the HOMAGE trial (2022)
Article in International Scientific Journal
Ferreira, JP; Verdonschot, JAJ; Girerd, N; Bozec, E; Pellicori, P; Collier, T; Mariottoni, B; Cosmi, F; Hazebroek, M; Cuthbert, J; Petutschnigg, J; Heymans, S; Staessen, JA; Pieske, B; Edelman, F; Clark, AL; Diez, J; Gonzalez, A; Rossignol, P; Cleland, JG...(mais 1 author)

Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER-like endpoint definitions (2022)
Article in International Scientific Journal
Anker, SD; Siddiqi, TJ; Filippatos, G; Zannad, F; Ferreira, JP; Pocock, SJ; Brueckmann, M; Zeller, C; Packer, M; Butler, J